About McCord Health

McCord Health and Research combines scientific research with medical product development to create a product portfolio that meets the needs of the institutional medicine complex.  

The demand for high-efficacy skin and wound care products has expanded over the past two decades and McCord Health and Research has remained an unapparelled industry leader.  The company’s products have treated millions of patients and more importantly it has done so with clinical outcomes that outpace the competition.   

Olivamine was originally developed in 2002.  Over the next 20 years the combinate ingredient has garnered 11 patents in categories that include wound care, nutrition, cancer, cell renewal and capillary integrity.  Research and product develop continues as new discoveries provide an ever-expanding platform for Olivamine-based products.

McCord Health and Research is expanding into treatments for bacterial and fungal diseases within the global medical and agriculture fields.  The company has two pending patents that cover the elimination of pathogens that cause disease and death in humans, animals and plants.  Clinical trials will start in 2021 to prove efficacy in wound care patients.  Studies are underway to evaluate the use of the technology as an enrichment for olive trees.

The company expects to expand its portfolio in 2021 as it moves into animal health and new products in skin science and nutrition.